Sex-Related Differences In Impact On Safety Of Pharmacogenetic Profile For Colon Cancer Patients Treated With Folfox-4 Or Xelox Adjuvant Chemotherapy (Vol 9, 11527, 2019) Annamaria Ruzzo , Francesco Graziano , Francesca Galli , Fabio Galli , Eliana Rulli , Sara Lonardi , Monica Ronzoni , Bruno Massidda , Vittorina Zagonel , Nicoletta Pella , Claudia Mucciarini , Roberto Labianca , Maria Teresa Ionta , Irene Bagaloni , Enzo Veltri , Pietro Sozzi , Sandro Barni , Vincenzo Ricci , Luisa Foltran , Mario Nicolini , Edoardo Biondi , Annalisa Bramati , Daniele Turci , Silvia Lazzarelli , Claudio Verusio , Francesca Bergamo , Alberto Sobrero , Luciano Frontini , Mauro Magnani SCIENTIFIC REPORTS（2020）
摘要
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
更多 查看译文
AI 理解论文
溯源树
样例
